On the Versatility of von Willebrand Factor
暂无分享,去创建一个
O. Christophe | P. Lenting | C. Denis | S. Susen | A. Rauch | N. Wohner
[1] J. Gill,et al. Variability in platelet‐ and collagen‐binding defects in type 2M von Willebrand disease , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[2] C. Casari,et al. Clearance of von Willebrand factor , 2013, Journal of thrombosis and haemostasis : JTH.
[3] M. Overgaard,et al. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. , 2013, Thrombosis research.
[4] P. Kamphuisen,et al. Reduced prevalence of arterial thrombosis in von Willebrand disease , 2013, Journal of thrombosis and haemostasis : JTH.
[5] Giuseppe Lippi,et al. von Willebrand factor and cancer: a renewed interest. , 2013, Thrombosis research.
[6] M. Franchini,et al. Von Willebrand disease‐associated angiodysplasia: a few answers, still many questions , 2013, British journal of haematology.
[7] J. Moake,et al. Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis , 2013, PloS one.
[8] C. Casari,et al. Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein. , 2013, Blood.
[9] R. Ljung,et al. Factor VIII products and inhibitor development in severe hemophilia A. , 2013, The New England journal of medicine.
[10] S. D. De Meyer,et al. Unwinding the von Willebrand factor strings puzzle. , 2013, Blood.
[11] C. Casari,et al. Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5 , 2012, Haematologica.
[12] C. Casari,et al. von Willebrand factor: the old, the new and the unknown , 2012, Journal of thrombosis and haemostasis : JTH.
[13] K. Mertens,et al. Distinct Roles of Ser-764 and Lys-773 at the N Terminus of von Willebrand Factor in Complex Assembly with Coagulation Factor VIII* , 2012, The Journal of Biological Chemistry.
[14] R. Montgomery,et al. Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo , 2012, Journal of thrombosis and haemostasis : JTH.
[15] Qiong Wang,et al. The unfolded von Willebrand factor response in bloodstream: the self-association perspective , 2012, Journal of Hematology & Oncology.
[16] C. Casari,et al. A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor. , 2012, Blood.
[17] Shannon L Meeks,et al. A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function. , 2012, Blood.
[18] R. Schutgens,et al. Von Willebrand factor deficiency and atherosclerosis. , 2012, Blood reviews.
[19] D. Wagner,et al. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[20] D. Motto,et al. ADAMTS13 reduces VWF‐mediated acute inflammation following focal cerebral ischemia in mice , 2012, Journal of thrombosis and haemostasis : JTH.
[21] T. Walz,et al. Sequence and structure relationships within von Willebrand factor. , 2012, Blood.
[22] D. Bellissimo,et al. Critical von Willebrand factor A1 domain residues influence type VI collagen binding , 2012, Journal of thrombosis and haemostasis : JTH.
[23] C. Millar,et al. Characterisation of von Willebrand factor A1 domain mutants I1416N and I1416T: correlation of clinical phenotype with flow‐based platelet adhesion , 2012, Journal of thrombosis and haemostasis : JTH.
[24] H. Okano,et al. Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor. , 2012, Journal of the National Cancer Institute.
[25] W. Hauswirth,et al. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] P. James,et al. von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies , 2012, American journal of hematology.
[27] R. Bierings,et al. Proteomic screen identifies IGFBP7 as a novel component of endothelial cell-specific Weibel-Palade bodies. , 2012, Journal of proteome research.
[28] P. Lenting,et al. Current understanding of thrombosis and hemostasis — from bench to bedside von Willebrand factor : at the crossroads of bleeding and thrombosis , 2012 .
[29] Riyao Yang,et al. Galectins in acute and chronic inflammation , 2012, Annals of the New York Academy of Sciences.
[30] P. D. de Groot,et al. Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[31] P. Mannucci,et al. Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients , 2012, Journal of thrombosis and haemostasis : JTH.
[32] A. Hofman,et al. Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam Study , 2012, Journal of thrombosis and haemostasis : JTH.
[33] E. Huizinga,et al. Implications for collagen I chain registry from the structure of the collagen von Willebrand factor A3 domain complex , 2012, Proceedings of the National Academy of Sciences.
[34] A. Chauhan,et al. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. , 2012, Blood.
[35] C. Casari,et al. Macrophage LRP1 contributes to the clearance of von Willebrand factor. , 2012, Blood.
[36] N. Gupta,et al. Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.
[37] L. Thompson,et al. Parotid Gland Solitary Fibrous Tumor: A Case Report and Clinicopathologic Review of 22 Cases from the Literature , 2012, Head and Neck Pathology.
[38] Michael M. Wang,et al. von Willebrand Factor Permeates Small Vessels in CADASIL and Inhibits Smooth Muscle Gene Expression , 2012, Translational Stroke Research.
[39] E. Boerwinkle,et al. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. , 2012, Blood.
[40] L. Thim,et al. High Affinity Binding of FVIII to VWF Is Not Required for the Haemostatic Effect of FVIII In Vivo , 2011 .
[41] T. Walz,et al. A pH‐regulated dimeric bouquet in the structure of von Willebrand factor , 2011, The EMBO journal.
[42] D. Lane,et al. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. , 2011, Blood.
[43] T. Springer,et al. Biology and physics of von Willebrand factor concatamers , 2011, Journal of thrombosis and haemostasis : JTH.
[44] R. Schneppenheim,et al. von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein , 2011, Journal of thrombosis and haemostasis : JTH.
[45] D. Strachan,et al. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. , 2011, Blood.
[46] A. Hughes,et al. Endothelial von Willebrand factor regulates angiogenesis. , 2011, Blood.
[47] C. Denis,et al. Novel Function of Tenascin-C, a Matrix Protein Relevant to Atherosclerosis, in Platelet Recruitment and Activation Under Flow , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[48] A. Zarbock,et al. von Willebrand factor promotes leukocyte extravasation. , 2010, Blood.
[49] Junmei Chen,et al. Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region. , 2010, Blood.
[50] Z. Ruggeri,et al. Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib , 2010, Thrombosis and Haemostasis.
[51] G. Stoll,et al. Binding of von Willebrand Factor to Collagen and Glycoprotein Ib&agr;, But Not to Glycoprotein IIb/IIIa, Contributes to Ischemic Stroke in Mice—Brief Report , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[52] A. Hofman,et al. High von Willebrand Factor Levels Increase the Risk of Stroke: The Rotterdam Study , 2010, Stroke.
[53] G. Lippi,et al. Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia A , 2010, Thrombosis and Haemostasis.
[54] M. Slaughter. Hematologic Effects of Continuous Flow Left Ventricular Assist Devices , 2010, Journal of cardiovascular translational research.
[55] P. D. de Groot,et al. Regulation of von Willebrand factor-platelet interactions , 2010, Thrombosis and Haemostasis.
[56] F. Rosendaal,et al. Risk factors for venous thrombosis – current understanding from an epidemiological point of view , 2010, British journal of haematology.
[57] R. Hoffmann,et al. Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD , 2010, Journal of thrombosis and haemostasis : JTH.
[58] A. Goodeve. The genetic basis of von Willebrand disease. , 2010, Blood reviews.
[59] T. Miyata,et al. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion. , 2010, Blood.
[60] C. Ruan,et al. The glycoprotein Ibα–von Willebrand factor interaction induces platelet apoptosis , 2010, Journal of thrombosis and haemostasis : JTH.
[61] J. Sadler,et al. Multi‐step binding of ADAMTS‐13 to von Willebrand factor , 2009, Journal of thrombosis and haemostasis : JTH.
[62] B. Sorg,et al. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. , 2009, The Journal of clinical investigation.
[63] M. Laffan,et al. Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor. , 2009, Blood.
[64] A. Chauhan,et al. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. , 2009, Blood.
[65] P. Lenting,et al. A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF. , 2009, Blood.
[66] J. Sadler. von Willebrand factor assembly and secretion , 2009, Journal of thrombosis and haemostasis : JTH.
[67] Cheng-Zhong Zhang,et al. Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor , 2009, Science.
[68] M. Jacquemin. Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A , 2009, Acta Haematologica.
[69] E. Willebrand. Über hereditäre Pseudohämophilie. , 2009 .
[70] I. Nilsson,et al. Von Willebrand's disease and its correction with human plasma fraction 1-0. , 2009, Acta medica Scandinavica.
[71] R. Kiss,et al. Galectins and Gliomas , 2009, Brain pathology.
[72] H. Tsai. Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura. , 2009, Kidney international. Supplement.
[73] Z. Ruggeri,et al. Platelet Adhesion under Flow , 2009, Microcirculation.
[74] M. Berndt,et al. Platelet adhesion: a game of catch and release. , 2008, The Journal of clinical investigation.
[75] J. Zachary,et al. von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis. , 2008, The American journal of pathology.
[76] O. Christophe,et al. Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa. , 2008, Blood.
[77] J. Moake,et al. Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions , 2008, Journal of thrombosis and haemostasis : JTH.
[78] Y. Ozaki,et al. Redundant Mechanism of Platelet Adhesion to Laminin and Collagen under Flow , 2008, Journal of Biological Chemistry.
[79] P. Lenting,et al. Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13 , 2008, Proceedings of the National Academy of Sciences.
[80] B. Jilma,et al. Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes , 2008, Circulation.
[81] O. Christophe,et al. Correction of Bleeding Symptoms in von Willebrand Factor–Deficient Mice by Liver-Expressed von Willebrand Factor Mutants , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[82] A. Chauhan,et al. Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice , 2008, Thrombosis and Haemostasis.
[83] J. Goudemand. Inhibitor development in haemophilia A: the role of von Willebrand factor/factor VIII concentrates , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.
[84] O. Christophe,et al. Characterization of the interaction between von Willebrand factor and osteoprotegerin , 2007, Journal of thrombosis and haemostasis : JTH.
[85] P. Lenting,et al. Clearance mechanisms of von Willebrand factor and factor VIII , 2007, Journal of thrombosis and haemostasis : JTH.
[86] Z. Ruggeri. Von Willebrand factor: Looking back and looking forward , 2007, Thrombosis and Haemostasis.
[87] G. Auerswald,et al. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study. , 2007, Blood.
[88] S. Kaveri,et al. A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes , 2007, Proceedings of the National Academy of Sciences.
[89] A Alexander-Katz,et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers , 2007, Proceedings of the National Academy of Sciences.
[90] P. Hogg,et al. Hypothesis for control of von Willebrand factor multimer size by intra‐molecular thiol‐disulphide exchange , 2007, Journal of thrombosis and haemostasis : JTH.
[91] Sriram Neelamegham,et al. Solution Structure of Human von Willebrand Factor Studied Using Small Angle Neutron Scattering* , 2006, Journal of Biological Chemistry.
[92] C. Gahmberg,et al. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. , 2006, Blood.
[93] Richard W Farndale,et al. A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. , 2006, Blood.
[94] A. Chauhan,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins , 2007 .
[95] R. Romijn,et al. von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen , 2006, Journal of thrombosis and haemostasis : JTH.
[96] J. V. van Mourik,et al. Unraveling the mystery of von Willebrand factor , 2006, Journal of thrombosis and haemostasis : JTH.
[97] D Meyer,et al. Increased metastatic potential of tumor cells in von Willebrand factor‐deficient mice , 2006, Journal of thrombosis and haemostasis : JTH.
[98] M. Crúz,et al. The interaction of von Willebrand factor‐A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen , 2006, Journal of thrombosis and haemostasis : JTH.
[99] W. Owen. Big piece, little piece or: Yes, factor VIII is a protein , 2005, Journal of thrombosis and haemostasis : JTH.
[100] A. Zannettino,et al. Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor , 2005, Journal of cellular physiology.
[101] J. Moake,et al. Platelets adhered to endothelial cell‐bound ultra‐large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress , 2005, Journal of thrombosis and haemostasis : JTH.
[102] P. Mannucci,et al. Plasma levels of von Willebrand factor regulate ADAMTS‐13, its major cleaving protease , 2004, British journal of haematology.
[103] L. Mosyak,et al. Crystal Structure of the Wild-type von Willebrand Factor A1-Glycoprotein Ibα Complex Reveals Conformation Differences with a Complex Bearing von Willebrand Disease Mutations* , 2004, Journal of Biological Chemistry.
[104] Vilmundur Gudnason,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.
[105] D. Arveiler,et al. Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study , 2004, Circulation.
[106] S. Susen,et al. Acquired von Willebrand syndrome in aortic stenosis. , 2003, The New England journal of medicine.
[107] S. Watson,et al. Platelet-collagen interaction: is GPVI the central receptor? , 2003, Blood.
[108] J. Sixma,et al. Mapping the Collagen-binding Site in the von Willebrand Factor-A3 Domain* , 2003, The Journal of Biological Chemistry.
[109] H. Dardik,et al. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies. , 2003, Journal of vascular surgery.
[110] A. Folsom,et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.
[111] J. Danesh,et al. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. , 2002, European heart journal.
[112] J. Sixma,et al. Structures of Glycoprotein Ibα and Its Complex with von Willebrand Factor A1 Domain , 2002, Science.
[113] J. Saint-Remy,et al. Von Willebrand Factor Modulates Factor VIII Immunogenicity: Comparative Study of Different Factor VIII Concentrates in a Haemophilia A Mouse Model , 2002, Thrombosis and Haemostasis.
[114] H. Deckmyn,et al. Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. , 2002, Blood.
[115] T. Foroud,et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura , 2001, Nature.
[116] J. Lavergne,et al. Ser968Thr Mutation within the A3 Domain of Von Willebrand Factor (VWF) in Two Related Patients Leads to a Defective Binding of VWF to Collagen , 2001, Thrombosis and Haemostasis.
[117] D. Wagner,et al. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. , 2001, Blood.
[118] M. Massot,et al. Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[119] P. Hogg,et al. Control of Von Willebrand Factor Multimer Size by Thrombospondin-1 , 2001, The Journal of experimental medicine.
[120] C. Denis,et al. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[121] G. D. De Meyer,et al. Intimal deposition of functional von Willebrand factor in atherogenesis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[122] J. V. van Mourik,et al. The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein* , 1999, The Journal of Biological Chemistry.
[123] A. Folsom,et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1999, Circulation.
[124] José A López,et al. The Glycoprotein Ib-IX-V Complex in Platelet Adhesion and Signaling , 1999, Thrombosis and Haemostasis.
[125] G. E. Gilbert,et al. Collagen-bound von Willebrand Factor Has Reduced Affinity for Factor VIII* , 1999, The Journal of Biological Chemistry.
[126] J. Vermylen,et al. A New Animal Model of Thrombophilia Confirms that High Plasma Factor VIII Levels Are Thrombogenic , 1999, Thrombosis and Haemostasis.
[127] H. Tsai,et al. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. , 1998, The New England journal of medicine.
[128] B. Lämmle,et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. , 1998 .
[129] R. Hynes,et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[130] E. Vicaut,et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. , 1998, Circulation.
[131] M. Lewis,et al. Redistribution of von Willebrand factor in porcine carotid arteries after balloon angioplasty. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[132] José A López,et al. Structure and function of the glycoprotein Ib‐IX‐V complex , 1997, Current opinion in hematology.
[133] E. Saenko,et al. The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor* , 1997, The Journal of Biological Chemistry.
[134] J. Sixma,et al. Platelet Adhesion to Collagen: an Update , 1997, Thrombosis and Haemostasis.
[135] M. Hoylaerts,et al. von Willebrand factor binds to native collagen VI primarily via its A1 domain. , 1997, The Biochemical journal.
[136] C. Vrints,et al. Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[137] K. Amano,et al. Factor VIII Inhibitor Antibodies with C2 Domain Specificity Are Less inhibitory to Factor VIII Complexed with von Willebrand Factor , 1996, Thrombosis and Haemostasis.
[138] R. Marchant,et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. , 1996, Blood.
[139] J. Sixma,et al. A3 Domain Is Essential for Interaction of von Willebrand Factor with Collagen Type III , 1996, Thrombosis and Haemostasis.
[140] K. Amano,et al. Autoantibody to factor VIII that has less reactivity to factor Vlll/von Willebrand Factor Complex , 1995, American journal of hematology.
[141] J. Sixma,et al. Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. , 1995, Blood.
[142] R. Handin,et al. Interaction of the von Willebrand Factor (vWF) with Collagen , 1995, The Journal of Biological Chemistry.
[143] S. Thompson,et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.
[144] J. Vandenbroucke,et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.
[145] A. Zaleski,et al. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. , 1994, The Journal of laboratory and clinical medicine.
[146] P. Lenting,et al. Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII. , 1994, The Journal of biological chemistry.
[147] É. Fressinaud,et al. International Survey of Patients with von Willebrand Disease and Angiodysplasia , 1993, Thrombosis and Haemostasis.
[148] P. Mannucci,et al. Pharmacokinetics of Monoclonally-Purified and Recombinant Factor VIII in Patients with Severe von Willebrand Disease , 1993, Thrombosis and Haemostasis.
[149] D. Baruch,et al. Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[150] D. A. Beacham,et al. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. , 1992, The Journal of biological chemistry.
[151] J. Sadler. von Willebrand factor. , 1991, The Journal of biological chemistry.
[152] A. Giles,et al. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. , 1991, The Journal of biological chemistry.
[153] P. Fay,et al. von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. , 1991, The Journal of biological chemistry.
[154] C. Niehrs,et al. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. , 1991, The Journal of biological chemistry.
[155] D. Tate,et al. von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. , 1990, Arteriosclerosis.
[156] J. Sixma,et al. The effect of von Willebrand factor on activation of factor VIII by factor Xa. , 1990, European journal of biochemistry.
[157] H. Mohri,et al. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites. , 1989, The Journal of biological chemistry.
[158] C. Rothschild,et al. New variant of von Willebrand disease with defective binding to factor VIII. , 1989, Blood.
[159] J. Voorberg,et al. 5 Molecular cloning, expression and assembly of multimeric von Willebrand factor* , 1989 .
[160] J. V. van Mourik,et al. The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. , 1989, The Biochemical journal.
[161] D. Baruch,et al. von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib. , 1988, The Journal of laboratory and clinical medicine.
[162] D. Meyer,et al. Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. , 1987, Blood.
[163] J. McPherson,et al. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. , 1987, The Journal of biological chemistry.
[164] K. Titani,et al. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. , 1987, The Journal of biological chemistry.
[165] L. Holland,et al. Isolation and characterization of a collagen binding domain in human von Willebrand factor. , 1986, The Journal of biological chemistry.
[166] P. Diergaarde,et al. Full‐length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. , 1986, The EMBO journal.
[167] G. Soff,et al. The von Willebrand Factor in Myocardial Infarction and Unstable Angina: A Kinetic Study , 1986, Thrombosis and Haemostasis.
[168] R. D. Wade,et al. Amino acid sequence of human von Willebrand factor. , 1986, Biochemistry.
[169] K. Titani,et al. Cloning and characterization of two cDNAs coding for human von Willebrand factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[170] D. Wagner,et al. Biosynthesis of von Willebrand protein by human megakaryocytes. , 1985, The Journal of clinical investigation.
[171] S. Latt,et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. , 1985, Science.
[172] C. J. Collins,et al. Molecular cloning of cDNA for human von willebrand factor: Authentication by a new method , 1985, Cell.
[173] D. Wagner,et al. Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain. , 1983, The Journal of biological chemistry.
[174] E. Tuddenham,et al. Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease , 1982, British journal of haematology.
[175] R. Montgomery,et al. Newborn Factor VIII Complex: Elevated Activities in Term Infants and Alterations in Electrophoretic Mobility Related to Illness and Activated Coagulatio , 1981, British journal of haematology.
[176] S. Santoro. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens. , 1981, Thrombosis research.
[177] D. Nyman. Interaction of collagen with the factor VIII antigen-activity - von Willebrand factor complex. , 1977, Thrombosis research.
[178] I. Sussman,et al. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. , 1977, The Journal of clinical investigation.
[179] H. Deckmyn,et al. Platelet adhesion to collagen. , 2011, Thrombosis research.
[180] J. Sadler,et al. Low von Willebrand factor: sometimes a risk factor and sometimes a disease. , 2009, Hematology. American Society of Hematology. Education Program.
[181] C. Denis,et al. Role of von Willebrand factor in tumor metastasis. , 2007, Thrombosis research.
[182] T. Lambert,et al. Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A. , 2006, Blood.
[183] N. Shimba,et al. Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment , 2003, Nature Structural Biology.
[184] J. Spivak,et al. Commentary on and reprint of von Willebrand EA, Über hereditäre Pseudohämophilie [On hereditary pseudohemophilia], in Acta Medica Scandinavica (1931) 76:521–549 , 2000 .
[185] B. Lämmle,et al. Recovery and Half-Life of von Willebrand Factor-Cleaving Protease after Plasma Therapy in Patients with Thrombotic Thrombocytopenic Purpura , 1999, Thrombosis and Haemostasis.
[186] F. Cohen,et al. Biochemistry and genetics of von Willebrand factor. , 1998, Annual review of biochemistry.
[187] D. Wagner. Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.
[188] J. Voorberg,et al. Molecular cloning, expression and assembly of multimeric von Willebrand factor. , 1989, Bailliere's clinical haematology.
[189] I. Sussman,et al. STUDIES ON POSTTRANSFUSION AND DISSOCIATED FACTOR VIII AND IN PATIENTS WITH VON WILLEBRAND'S DISEASE , 1977 .